Latest Health News

Aroa Biosurgery has reported its first quarter of positive operating cash flow since listing on the ASX in 2020, alongside robust revenue growth projections and new regulatory approvals across key international markets.

4DMedical reports a remarkable 202% increase in Q2 FY2025 operating revenue, driven by rapid site expansion and key collaborations with leading healthcare providers and the U.S. Department of Defense.

Mitchell Services reported a $46.7 million revenue and $5.6 million EBITDA in Q2 FY25, reflecting a strategic transition phase marked by increased mobilisation for new projects in PNG and decarbonisation drilling. Despite short-term softness, the company’s strengthened balance sheet and expanded service offerings position it for growth.

Meeka Metals has made substantial strides in developing its Murchison Gold Project, backed by a fully funded expansion and a robust feasibility study projecting $1 billion in pre-tax free cash flow over 10 years. With first gold targeted for mid-2025, infrastructure and mining operations are advancing ahead of schedule.

Bulletin Resources continues its appeal against the refusal of a Native Vegetation Clearing Permit critical to advancing drilling at its Ravensthorpe Lithium Project, while maintaining a strong cash position and reviewing strategic opportunities.

K2 Asset Management has appointed longtime executive Hollie Wight as CEO, signaling a strategic push towards sustained profitability and diversified revenue growth in 2025.

Magnis Energy Technologies reveals that its partners IM3NY LLC and Imperium3 New York Inc have entered Chapter 11 bankruptcy proceedings, raising questions about future operations and financial stability.

Foresta Group Holdings has raised $3.1 million through a convertible note and share placement, while securing exclusive technology licensing and key offtake agreements to propel its flagship New Zealand biomass project.

Singular Health has secured a pivotal MoU with Miami-based Provider Network Solutions and raised $3.7 million to propel its 3Dicom software towards a US commercial pilot, supported by the appointment of esteemed radiologist Dr. Ronny Low.

TrivarX has secured positive feedback from the FDA on its pivotal trial design for MEB-001, an AI-driven algorithm targeting major depressive episode screening via sleep study data. The company is advancing site collaborations to launch a large-scale US trial.

Anatara Lifesciences has been granted a key Australian patent for its GaRP gastrointestinal health product, reinforcing its intellectual property portfolio ahead of pivotal clinical trial results expected in March 2025.

PARKD Ltd reports substantial structural completions on flagship projects and positive operating cash flow in Q2 FY25, setting the stage for licensing negotiations with Fielders.